project id: TCGA-HNSC; case submitter id: TCGA-HD-A4C1; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 9.5; age at index: 41; days to birth: -15096; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1971; age at diagnosis: 15096; ajcc clinical m: M0; ajcc clinical n: N2; ajcc clinical stage: Stage IVA; ajcc clinical t: T3; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 11.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: not reported; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 67; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-HD-A4C1-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 10.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 60.0; percent tumor cells: 30.0; percent tumor nuclei: 75.0;